Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cigarettes are a form of tobacco product made from the dried leaves of the tobacco plant (primarily Nicotiana tabacum and Nicotiana rustica), rolled in paper for smoking. The primary psychoactive and addictive component in cigarettes is nicotine, an alkaloid that acts as an agonist at nicotinic cholinergic receptors in the nervous system. When smoked, nicotine produces both stimulant and depressant effects on the body. Cigarette smoke exposes users to over 7,000 chemicals—including more than 70 known carcinogens—making it a major cause of cancer (especially lung cancer), cardiovascular disease (such as heart attacks and stroke), chronic obstructive pulmonary disease (COPD), diabetes, ulcers, osteoporosis, rheumatoid arthritis, and other serious health conditions. Combustion of tobacco also generates carbon monoxide and other toxic substances that contribute to its harmful effects[1][3][6][8]. Cigarettes are legal but highly regulated products worldwide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cigarette.